Evercore ISI lowered its price target on Allscripts (NASDAQ: MDRX) to $13.00 (from $14.00) while maintaining a Outperform rating.

Analyst PT Change

Allscripts (MDRX) PT Lowered to $14.50 at RBC CapitalMay 4, 2018 8:20 AM SunTrust Robinson Humphrey Upgrades Allscripts (MDRX) to BuyMay 4, 2018 7:10 AM Allscripts (MDRX) to Buy HealthGridMay 3, 2018 4:52 PM Allscripts (MDRX) Misses Q1 EPS by 1c, Affirms OutlookMay 3, 2018 4:04 PM Form 8-K ALLSCRIPTS HEALTHCARE For: Apr 27May 3, 2018 4:03 PM Allscripts announces first quarter 2018 resultsMay 3, 2018 4:02 PM Allscripts to significantly expand FollowMyHealth® patient engagement platform portfolio with new, advanced capabilities through acquisition of HealthGridMay 3, 2018 4:01 PM